Tomasz Julian Majszyk
age 29Currently 8 roles in 4 KRS entities. In the KRS since 2018.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Inplasmed sp. z o.o. |
since Oct 31, 2023 | Oct 31, 2023 | ul. Kaliny Jędrusik 9/U2, 01-748 Warszawa |
Okulistyka sp. z o.o. |
since Mar 19, 2024 | Mar 19, 2024 | ul. Gen. Klemensa Stanisława Rudnickiego 3A/62, 01-858 Warszawa |
SPES Medica sp. z o.o. |
since May 7, 2018 | May 7, 2018 | ul. Kaliny Jędrusik 9/U2, 01-748 Warszawa |
SPES Unica Medica sp. z o.o. |
since Nov 14, 2024 | Nov 14, 2024 | ul. Kaliny Jędrusik 9/U2, 01-748 Warszawa |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Business suspended | – Okulistyka sp. z o.o. | Okulistyka sp. z o.o. | |
| Company founded | President of the Management Board, Partner (12.56% of shares worth PLN 25,000) SPES Unica Medica sp. z o.o. | SPES Unica Medica sp. z o.o. | |
| Company founded | President of the Management Board, Partner (40% of shares worth PLN 2,000) Okulistyka sp. z o.o. | Okulistyka sp. z o.o. | |
| Company founded | Management Board Member, Partner (10% of shares worth PLN 2,000) Inplasmed sp. z o.o. | Inplasmed sp. z o.o. | |
| Appointed | President of the Management Board SPES Medica sp. z o.o. | SPES Medica sp. z o.o. | |
| Company founded | Partner (10% of shares worth PLN 1,000) SPES Medica sp. z o.o. | SPES Medica sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation |
|
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Tomasz Adam Majszykage 69 | since Oct 31, 2023 | ||
Karol Paweł Knopage 37 | Inplasmed sp. z o.o. | since Oct 31, 2023 | |
Inplasmed sp. z o.o. | current (no date in KRS) | ||
Agata Bełżeckaage 56 | Okulistyka sp. z o.o. | since Mar 19, 2024 |